Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham

Stem cell culture media NCH421K cells primary glioma

Experiment
Stem cell culture media NCH421K cells primary glioma
Product
Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham from Sigma-Aldrich
Manufacturer
Sigma-Aldrich

Protocol tips

Protocol tips
DMEM/F12 medium supplemented with 0.25 % BSA, 1 % ITS, 20 ng/mL epidermal growth factor (EGF) and 20 ng/mL basic fibroblast growth factor (bFGF)

Publication protocol

DMEM/F12 medium supplemented with 0.25 % BSA, 1 % ITS, 20 ng/mL epidermal growth factor (EGF) and 20 ng/mL basic fibroblast growth factor (bFGF)

Full paper   Login or join for free to view the full paper.

Reviews

Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham from Sigma-Aldrich has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Stem cell culture media NCH421K cells primary glioma using Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham from Sigma-Aldrich.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Sigma-Aldrich for Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Stem cell culture media NCH421K cells primary glioma using Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham from Sigma-Aldrich. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms